Tag: krazati fda approval
Mirati Wins FDA OK for KRAS Lung Cancer Pill Krazati
For decades, the KRAS gene was considered undruggable. A single mutation in it drives roughly one in seven non-small cell lung cancers. On December 15, 2022, th
